MedPage Today -- LITTLE FALLS, N.J., May 14 -- Certolizumab pegol (Cimzia) has been approved by the FDA for adult patients with moderately to severely active rheumatoid arthritis, UCB, the maker of the drug, announced.
MedPage Today -- LITTLE FALLS, N.J., May 14 -- Certolizumab pegol (Cimzia) has been approved by the FDA for adult patients with moderately to severely active rheumatoid arthritis, UCB, the maker of the drug, announced.